BCRP expression was significantly upregulated in YD-8/CIS and YD-38/CIS cells, and MDR1 expression was significantly upregulated in YD-9/CIS cells; these results were confirmed via Western blotting. Here, ABCG2 is linked to in situ carcinoma.